Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation

Kelly A. Moore, Kayla M. Pate, Deborah D. Soto-Ortega, Samuel Lohse, Nicholas van der Munnik, Mihyun Lim, Kaliah S. Jackson, Venetia D. Lyles, Lemeisha Jones, Nisha Glassgow, Vanessa M. Napumecheno, Shanee Mobley, Mark J. Uline, Rahina Mahtab, Catherine J. Murphy, Melissa A. Moss

Research output: Contribution to journalArticle

Abstract

Background: Deposits of aggregated amyloid-β protein (Aβ) are a pathological hallmark of Alzheimer's disease (AD). Thus, one therapeutic strategy is to eliminate these deposits by halting Aβ aggregation. While a variety of possible aggregation inhibitors have been explored, only nanoparticles (NPs) exhibit promise at low substoichiometric ratios. With tunable size, shape, and surface properties, NPs present an ideal platform for rationally designed Aβ aggregation inhibitors. In this study, we characterized the inhibitory capabilities of gold nanospheres exhibiting different surface coatings and diameters. Results: Both NP diameter and surface chemistry were found to modulate the extent of aggregation, while NP electric charge influenced aggregate morphology. Notably, 8nm and 18nm poly(acrylic acid)-coated NPs abrogated Aβ aggregation at a substoichiometric ratio of 1:2,000,000. Theoretical calculations suggest that this low stoichiometry could arise from altered solution conditions near the NP surface. Specifically, local solution pH and charge density are congruent with conditions that influence aggregation. Conclusions: These findings demonstrate the potential of surface-coated gold nanospheres to serve as tunable therapeutic agents for the inhibition of Aβ aggregation. Insights gained into the physiochemical properties of effective NP inhibitors will inform future rational design of effective NP-based therapeutics for AD.

Original languageEnglish (US)
Article number5
JournalJournal of Biological Engineering
Volume11
Issue number1
DOIs
StatePublished - Feb 6 2017

Fingerprint

Amyloidogenic Proteins
Surface chemistry
Gold
Nanoparticles
Alzheimer Disease
Agglomeration
Nanospheres
carbopol 940
Deposits
Serum Amyloid A Protein
Electric charge
Surface Properties
Charge density
Stoichiometry
Acrylics
Surface properties
Therapeutics
Coatings
Acids

Keywords

  • Aggregate morphology
  • Alzheimer's disease
  • Amyloid-β protein
  • Gold nanoparticles
  • Inhibition
  • Protein aggregation

ASJC Scopus subject areas

  • Environmental Engineering
  • Biomedical Engineering
  • Molecular Biology
  • Cell Biology

Cite this

Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation. / Moore, Kelly A.; Pate, Kayla M.; Soto-Ortega, Deborah D.; Lohse, Samuel; van der Munnik, Nicholas; Lim, Mihyun; Jackson, Kaliah S.; Lyles, Venetia D.; Jones, Lemeisha; Glassgow, Nisha; Napumecheno, Vanessa M.; Mobley, Shanee; Uline, Mark J.; Mahtab, Rahina; Murphy, Catherine J.; Moss, Melissa A.

In: Journal of Biological Engineering, Vol. 11, No. 1, 5, 06.02.2017.

Research output: Contribution to journalArticle

Moore, KA, Pate, KM, Soto-Ortega, DD, Lohse, S, van der Munnik, N, Lim, M, Jackson, KS, Lyles, VD, Jones, L, Glassgow, N, Napumecheno, VM, Mobley, S, Uline, MJ, Mahtab, R, Murphy, CJ & Moss, MA 2017, 'Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation', Journal of Biological Engineering, vol. 11, no. 1, 5. https://doi.org/10.1186/s13036-017-0047-6
Moore, Kelly A. ; Pate, Kayla M. ; Soto-Ortega, Deborah D. ; Lohse, Samuel ; van der Munnik, Nicholas ; Lim, Mihyun ; Jackson, Kaliah S. ; Lyles, Venetia D. ; Jones, Lemeisha ; Glassgow, Nisha ; Napumecheno, Vanessa M. ; Mobley, Shanee ; Uline, Mark J. ; Mahtab, Rahina ; Murphy, Catherine J. ; Moss, Melissa A. / Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation. In: Journal of Biological Engineering. 2017 ; Vol. 11, No. 1.
@article{41500f67c05f407c94316abd3fd0618f,
title = "Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation",
abstract = "Background: Deposits of aggregated amyloid-β protein (Aβ) are a pathological hallmark of Alzheimer's disease (AD). Thus, one therapeutic strategy is to eliminate these deposits by halting Aβ aggregation. While a variety of possible aggregation inhibitors have been explored, only nanoparticles (NPs) exhibit promise at low substoichiometric ratios. With tunable size, shape, and surface properties, NPs present an ideal platform for rationally designed Aβ aggregation inhibitors. In this study, we characterized the inhibitory capabilities of gold nanospheres exhibiting different surface coatings and diameters. Results: Both NP diameter and surface chemistry were found to modulate the extent of aggregation, while NP electric charge influenced aggregate morphology. Notably, 8nm and 18nm poly(acrylic acid)-coated NPs abrogated Aβ aggregation at a substoichiometric ratio of 1:2,000,000. Theoretical calculations suggest that this low stoichiometry could arise from altered solution conditions near the NP surface. Specifically, local solution pH and charge density are congruent with conditions that influence aggregation. Conclusions: These findings demonstrate the potential of surface-coated gold nanospheres to serve as tunable therapeutic agents for the inhibition of Aβ aggregation. Insights gained into the physiochemical properties of effective NP inhibitors will inform future rational design of effective NP-based therapeutics for AD.",
keywords = "Aggregate morphology, Alzheimer's disease, Amyloid-β protein, Gold nanoparticles, Inhibition, Protein aggregation",
author = "Moore, {Kelly A.} and Pate, {Kayla M.} and Soto-Ortega, {Deborah D.} and Samuel Lohse and {van der Munnik}, Nicholas and Mihyun Lim and Jackson, {Kaliah S.} and Lyles, {Venetia D.} and Lemeisha Jones and Nisha Glassgow and Napumecheno, {Vanessa M.} and Shanee Mobley and Uline, {Mark J.} and Rahina Mahtab and Murphy, {Catherine J.} and Moss, {Melissa A.}",
year = "2017",
month = "2",
day = "6",
doi = "10.1186/s13036-017-0047-6",
language = "English (US)",
volume = "11",
journal = "Journal of Biological Engineering",
issn = "1754-1611",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation

AU - Moore, Kelly A.

AU - Pate, Kayla M.

AU - Soto-Ortega, Deborah D.

AU - Lohse, Samuel

AU - van der Munnik, Nicholas

AU - Lim, Mihyun

AU - Jackson, Kaliah S.

AU - Lyles, Venetia D.

AU - Jones, Lemeisha

AU - Glassgow, Nisha

AU - Napumecheno, Vanessa M.

AU - Mobley, Shanee

AU - Uline, Mark J.

AU - Mahtab, Rahina

AU - Murphy, Catherine J.

AU - Moss, Melissa A.

PY - 2017/2/6

Y1 - 2017/2/6

N2 - Background: Deposits of aggregated amyloid-β protein (Aβ) are a pathological hallmark of Alzheimer's disease (AD). Thus, one therapeutic strategy is to eliminate these deposits by halting Aβ aggregation. While a variety of possible aggregation inhibitors have been explored, only nanoparticles (NPs) exhibit promise at low substoichiometric ratios. With tunable size, shape, and surface properties, NPs present an ideal platform for rationally designed Aβ aggregation inhibitors. In this study, we characterized the inhibitory capabilities of gold nanospheres exhibiting different surface coatings and diameters. Results: Both NP diameter and surface chemistry were found to modulate the extent of aggregation, while NP electric charge influenced aggregate morphology. Notably, 8nm and 18nm poly(acrylic acid)-coated NPs abrogated Aβ aggregation at a substoichiometric ratio of 1:2,000,000. Theoretical calculations suggest that this low stoichiometry could arise from altered solution conditions near the NP surface. Specifically, local solution pH and charge density are congruent with conditions that influence aggregation. Conclusions: These findings demonstrate the potential of surface-coated gold nanospheres to serve as tunable therapeutic agents for the inhibition of Aβ aggregation. Insights gained into the physiochemical properties of effective NP inhibitors will inform future rational design of effective NP-based therapeutics for AD.

AB - Background: Deposits of aggregated amyloid-β protein (Aβ) are a pathological hallmark of Alzheimer's disease (AD). Thus, one therapeutic strategy is to eliminate these deposits by halting Aβ aggregation. While a variety of possible aggregation inhibitors have been explored, only nanoparticles (NPs) exhibit promise at low substoichiometric ratios. With tunable size, shape, and surface properties, NPs present an ideal platform for rationally designed Aβ aggregation inhibitors. In this study, we characterized the inhibitory capabilities of gold nanospheres exhibiting different surface coatings and diameters. Results: Both NP diameter and surface chemistry were found to modulate the extent of aggregation, while NP electric charge influenced aggregate morphology. Notably, 8nm and 18nm poly(acrylic acid)-coated NPs abrogated Aβ aggregation at a substoichiometric ratio of 1:2,000,000. Theoretical calculations suggest that this low stoichiometry could arise from altered solution conditions near the NP surface. Specifically, local solution pH and charge density are congruent with conditions that influence aggregation. Conclusions: These findings demonstrate the potential of surface-coated gold nanospheres to serve as tunable therapeutic agents for the inhibition of Aβ aggregation. Insights gained into the physiochemical properties of effective NP inhibitors will inform future rational design of effective NP-based therapeutics for AD.

KW - Aggregate morphology

KW - Alzheimer's disease

KW - Amyloid-β protein

KW - Gold nanoparticles

KW - Inhibition

KW - Protein aggregation

UR - http://www.scopus.com/inward/record.url?scp=85011702016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011702016&partnerID=8YFLogxK

U2 - 10.1186/s13036-017-0047-6

DO - 10.1186/s13036-017-0047-6

M3 - Article

AN - SCOPUS:85011702016

VL - 11

JO - Journal of Biological Engineering

JF - Journal of Biological Engineering

SN - 1754-1611

IS - 1

M1 - 5

ER -